Correlation Between Lixte Biotechnology and Mustang Bio
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Mustang Bio, you can compare the effects of market volatilities on Lixte Biotechnology and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Mustang Bio.
Diversification Opportunities for Lixte Biotechnology and Mustang Bio
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lixte and Mustang is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Mustang Bio go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and Mustang Bio
Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to generate 0.42 times more return on investment than Mustang Bio. However, Lixte Biotechnology Holdings is 2.41 times less risky than Mustang Bio. It trades about 0.15 of its potential returns per unit of risk. Mustang Bio is currently generating about -0.12 per unit of risk. If you would invest 209.00 in Lixte Biotechnology Holdings on October 24, 2024 and sell it today you would earn a total of 24.00 from holding Lixte Biotechnology Holdings or generate 11.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lixte Biotechnology Holdings vs. Mustang Bio
Performance |
| Timeline |
| Lixte Biotechnology |
| Mustang Bio |
Lixte Biotechnology and Mustang Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lixte Biotechnology and Mustang Bio
The main advantage of trading using opposite Lixte Biotechnology and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
| Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |